NCFG
AZN icon

New Century Financial Group’s AstraZeneca AZN Stock Holding History

New Century Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,423
Closed -$209K – 112
2025
Q1 		$209K Sell
1,423
-4,324
-75% -$626K 0.24% 125
2024
Q4 		$761K Buy
5,747
+1,047
+22% +$147K 0.32% 88
2024
Q3 		$732K Buy
4,700
+2,400
+104% +$387K 0.27% 116
2024
Q2 		$359K Sell
2,300
-276
-11% -$41.5K 0.15% 176
2024
Q1 		$349K Sell
2,576
-483
-16% -$64K 0.24% 115
2023
Q4 		$412K Buy
+3,059
New +$398K 0.36% 96

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New Century Financial Group's AZN Position: Q2 2025 in Review

New Century Financial Group sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 1,423 shares — an estimated $209K sold.

New Century Financial Group first reported a position in AZN in Q4 2023 and held it in 6 quarters. The position peaked at $761K in Q4 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • New Century Financial Group reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • New Century Financial Group sold 1,423 AstraZeneca shares in Q2 2025, an estimated $209K.
  • New Century Financial Group first reported a position in AstraZeneca in Q4 2023 and held it in 6 quarters.
  • New Century Financial Group's AstraZeneca position peaked at $761K in Q4 2024.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on New Century Financial Group's 13F filing for Q2 2025, filed 21 Jul 2025.